Skip to main content
Erschienen in: Clinical and Translational Oncology 1/2013

01.01.2013 | Editorial

A 10-year step forward in hereditary cancer in Spain

verfasst von: B. Graña, J. Balmaña

Erschienen in: Clinical and Translational Oncology | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Excerpt

Genetic counselling in cancer is a multistep medical process that includes cancer risk assessment, evaluation of patient’s needs and concerns, education, genetic testing in selected cases, medical management, and psychosocial support. Potential benefits, limitations and risks of gene tests are important considerations in the decision-making process. The most detrimental factor in the development of genetic counselling in hereditary cancer in Spain in the late 90’s was the lack of certified formation and training in this field. To solve this gap, a tremendous effort has been done from the Spanish Society of Medical Oncology (SEOM) by promoting training courses, publishing books, guidelines, and consensus documents, fostering multidisciplinary meetings to address controversial issues, and participating in research projects. In June 2000, the first Spanish working group in hereditary cancer was created. A key priority was making genetic counselling in cancer accessible to anyone in Spain, uniting for this purpose the expertise of different motivated health professionals, such as oncologists, geneticists, nurses, psychologists, and others. …
Literatur
Metadaten
Titel
A 10-year step forward in hereditary cancer in Spain
verfasst von
B. Graña
J. Balmaña
Publikationsdatum
01.01.2013
Verlag
Springer Milan
Erschienen in
Clinical and Translational Oncology / Ausgabe 1/2013
Print ISSN: 1699-048X
Elektronische ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-012-0973-1

Weitere Artikel der Ausgabe 1/2013

Clinical and Translational Oncology 1/2013 Zur Ausgabe

Acknowledgements to Referees

Acknowledgements to Referees 2012

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.